Drug intelligence / Profile preview

Brix 3000

Development stage
Unknown
Lead developer
Brix
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Topical
01

Overview

Brix 3000 is an enzymatic gel formulation containing high concentrations of papain, utilized for chemo-mechanical caries removal (CMCR) in dentistry. Developed by Brix S.R.L., the product employs a specialized Encapsulated Buffer Emulsion (EBE) technology to stabilize the enzyme and ensure its proteolytic activity at an optimal pH. Brix 3000 selectively degrades the denatured collagen fibers in infected, necrotic dentin tissue while preserving the affected and healthy dentin. This softening of the carious tissue allows for its removal using simple manual instruments (such as excavators), which reduces or eliminates the need for conventional rotary drills (burs) and local anesthesia. This minimally invasive approach is particularly effective in pediatric dentistry, as it significantly reduces patient pain perception, fear, and anxiety associated with traditional restorative treatments.

Brand names
Brix 3000Brix3000Brix-3000Brix 3000™
Other names
Brix3000Brix-3000Brix 3000Brix 3000 gelBrix3000 gelBrix-3000 gelBrix 3oooBrix3oooBrix-3ooo

Beyond the preview

Go deeper on Brix 3000.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brix 3000.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call